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Summary Table 77 
What is known about this topic? 
• Blood pressure variability (BPV) has been shown to be associated with poor functional 
outcomes in acute ischemic stroke (AIS) and acute intracerebral hemorrhage (ICH). 
• Traditionally, AIS patients have been nursed in elevated positions (≥30°) due to concern over 
aspiration risk and propensity to reduce raised intracranial pressure. 
• However, disability outcomes do not differ between acute stroke patients nursed in a lying-flat 
position as compared to a head elevated position. 
• No studies have assessed the relationship between BPV and outcome following adjustment for 
head position.  
 
What this study adds? 
• This sub-study assessed the predictive potential of BPV on stroke outcomes considering the 
interaction with head positioning and any associated hemodynamic changes in relation to lying-
flat (increased cerebral blood flow and oxygenation) and sitting-up (potential reduction in ICP 
in large hemispheric AIS). 
• Systolic BPV was associated with unfavorable shift of the mRS at 90 days. 
• AIS etiology, stroke sub-type, head-position or use of reperfusion therapy did not interact with 
the predictive effects of systolic BPV on stroke outcome. 
• Diastolic BP was associated with unfavorable shift of the mRS at 90 days with a greater 
magnitude of effect of sitting-up head positioning on DBP variability and outcome.  
 
 78 
79 
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Abstract 80 
The Head Positioning in Acute Stroke Trial (HeadPoST) is a pragmatic, international, cluster 81 
crossover randomized trial of 11,093 patients with acute stroke assigned to a lying-flat (0o) or 82 
sitting-up (head elevated ≥30o) position. This post-hoc analysis aimed to determine the 83 
association between BPV and outcomes for patients from a wide range of international 84 
clinical settings and how the association was modified by randomized head position. BPV 85 
was defined according to standard criteria with the key parameter considered the coefficient 86 
of variation (CV) of systolic BP (SBP) over 24 hours. Outcome was ordinal 90-day modified 87 
Rankin Scale (mRS) score. The association was analyzed by ordinal, logistic regression, 88 
hierarchical, mixed models with fixed intervention (lying-flat vs. sitting-up), and fixed period, 89 
random cluster, and random cluster-period, effects. 9,156 (8,324 AIS and 817 ICH; mean age 90 
68.1 years; 39.2% women) were included in the analysis. CV of SBP had a significant linear 91 
association with unfavorable shift of mRS at 90 days (adjusted odds ratio [OR] 1.06, 95% 92 
confidence interval [CI] 1.02-1.11; P=0.01). There was no heterogeneity of the association by 93 
randomized head positioning. In addition, CV of diastolic BP (DBP) (1.08, 1.03-1.12; 94 
P=0.001) over 24 hours post stroke, was significantly associated with 3-month poor outcome. 95 
The association was more apparent in sitting-up position (1.12, 1.06-1.19) compared with 96 
lying-flat position (1.03, 0.98-1.09) (P interaction = 0.005). BPV was associated with adverse 97 
stroke outcome, the magnitude of the association was greater with sitting-up head positioning 98 
in terms of DBP variability. 99 
Clinical Trial Registration: clinicaltrials.gov (NCT02162017) 100 
101 
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Introduction 102 
The importance of specialized stroke units is evidenced by randomized trials demonstrating 103 
reductions in death and disability caused by prevention of secondary complications of stroke 104 
[1].  In acute stroke syndromes, elevated blood pressures (BP) have been a particular focus, as 105 
post-stroke hypertension precipitates secondary stroke complications [2].  More recently, BP 106 
variability (BPV), using widely applied measures such as standard deviation (SD) or 107 
coefficient of variation (CV), and measured early after acute ischemic stroke (AIS), 108 
intracerebral hemorrhage (ICH) or transient ischemic attack (TIA), has been shown to be 109 
associated with poor functional outcome [3-5]. 110 
Traditionally, AIS patients have been nursed in elevated positions (≥30°) due to concern over 111 
aspiration risk and propensity to reduce raised intracranial pressure (ICP) [6]. However, it is 112 
conceivable that head positioning may impact on BPV, with data from healthy individuals 113 
and AIS patients (in affected hemispheres) showing significant changes in cerebral 114 
hemodynamic parameters during head position changes of varying tilt [7,8]. 115 
The Head Positioning in Acute Stroke Trial (HeadPoST) was designed to evaluate whether 116 
outcomes for unselected acute stroke patients nursed lying-flat (i.e. fully supine with back 117 
horizontal and face upwards or to the side) were improved compared to those in a sitting-up 118 
position with head elevated to at least 30 degrees [9]. The study showed no significant 119 
difference in modified Rankin Scale (mRS) scores at 90 days between the head position 120 
groups initiated early after presentation and maintained for 24 hours. Accordingly, the 121 
HeadPoST results suggest any changes in cerebral blood flow based on head position initiated 122 
within 24 hours are insufficient to reduce the neurological deficit associated with acute stroke 123 
pathologies [9]. 124 
However, the potential impact of head positioning and any associated hemodynamic changes 125 
in relation to lying-flat (increased cerebral blood flow and oxygenation) and sitting-up 126 
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(potential reduction in ICP in large hemispheric AIS) on the predictive potential of BPV on 127 
outcome have yet to be considered.  Herein, we report the predictive potential of BPV 128 
parameters on functional outcome in a post-hoc individual patient analysis of the HeadPoST 129 
study. 130 
Materials and methods 131 
Patients 132 
HeadPoST was an international, multicenter, cluster-randomized, crossover, open trial with 133 
blinded outcome evaluation, conducted at 114 hospitals in nine countries [9]. The trial was 134 
designed to compare the effects of the lying-flat with the sitting-up position, initiated soon 135 
after stroke and maintained for 24 hours after the onset of acute stroke, full details of which 136 
are outlined elsewhere [9,10].  137 
Patients with a clinical diagnosis of acute stroke, including AIS and ICH, were included in 138 
order to facilitate consecutive patient recruitment.  Patients were excluded if the clinician-139 
investigator deemed either head position futile based on compliance or if a TIA was 140 
diagnosed.  Other reasons for exclusion were refusal to participate in the intervention and/or 141 
follow-up, or any contraindication to either head position.  Patients were assigned a head 142 
position according to the randomization cluster as soon as was feasible after admission to 143 
hospital and they were encouraged to strictly maintain this position for the next 24 hours.  144 
Interruption to the assigned head position was permitted, for three non-consecutive periods of 145 
less than 30 minutes, to permit eating, drinking and toileting, should this not have been 146 
possible in the assigned position. 147 
The appropriate ethics committee at each participating center approved the study protocol. A 148 
senior executive officer at each center acted as a ‘guardian’ and provided institutional consent 149 
for this low-risk intervention to be implemented consecutively as part of routine nursing care 150 
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in each cluster. Written informed consent was then sought from all patients or approved 151 
surrogates for ongoing assessments and data collection. 152 
Procedures 153 
Key demographic and clinical characteristics were recorded at the time of enrollment, 154 
including stroke severity measured using the National Institutes of Health stroke scale 155 
(NIHSS) at baseline, 24 hours, and at day 7 (or earlier, on discharge from hospital). A 24-156 
hour bed-side diary was maintained by the treating clinical nurses to record vital signs, lowest 157 
oxygen saturation and interruptions in head positioning. Follow-up data were collected at 7 158 
days (or at hospital discharge if before 7 days) unless death occurred earlier by independent 159 
outcome assessors blind to group allocation. Data included final diagnosis, repeat NIHSS 160 
score and assessment of functioning using the mRS, a standard disability scale with 161 
categorical scores ranging from 0 to 6 (0 indicates, no symptoms at all; 1, no clinically 162 
significant disability despite symptoms; 2, slight disability; 3, moderate disability requiring 163 
some help; 4, moderately severe disability requiring assistance with daily living; 5, severe 164 
disability, bed-bound, and incontinent; and 6, death). 165 
The primary clinical outcome was the ordinal mRS scores at 90 days.  BP was measured with 166 
a casual cuff at 4 hourly intervals during the first 24 hours post-stroke and BPV was 167 
calculated from all available BP measurements using BPV measures with demonstrable 168 
independence of mean SBP on an individual patient level. The parameters included were 169 
mean, standard deviation (SD), coefficient of variation (CV) and variation independent of 170 
mean (VIM, a transformation of SD that is defined to be uncorrelated with mean levels) as 171 
well as diastolic BPV over 24 hours (Table I in Supplementary Files).  There was an 172 
expectation that limited variation would exist in the standard BP measurement equipment 173 
used across different hospitals and countries. Coefficient of Variation (CV) [CV=SD/mean] 174 
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was derived from these parameters.  CV of SBP was categorized into 5 equal groups 175 
(quintiles), using the lowest fifth as the reference group. 176 
Statistical analysis 177 
We used ordinal, logistic regression, hierarchical, mixed models with fixed intervention 178 
(lying-flat vs. sitting-up), and fixed period, random cluster, and random cluster-period, effects 179 
to assess the associations. The multivariable model was adjusted for country, prestroke mRS 180 
score, age, sex, baseline NIHSS score, and history of heart disease, stroke or diabetes 181 
mellitus, or hypertension and prior antiplatelet therapy. We also investigated whether the 182 
associations were different between groups by AIS etiology, stroke sub-type and head 183 
position by adding an interaction term to the adjusted statistical models. In study analyses, 184 
two-sided P values are reported and P<0·05 was considered statistically significant.  The SAS 185 
version 9.3 (SAS Institute, Cary, NC) was used for all analyses. 186 
Results 187 
The HeadPoST trial included 11,093 patients (39.9% female) whose mean age was 68 years; 188 
patients without a mean systolic BP (46), without 90-day mRS (1,214) and those with a stroke 189 
mimic, TIA or undeterminated diagnosis (677) were excluded.  9,156 patients (82.5%) had a 190 
complete set of 4-hourly BP measurements recorded over the first 24 hours, on which 191 
subsequent analyses were undertaken. The study procedures are summarised in a flowchart 192 
(Fig.1). Those excluded at baseline were more likely to be female, have a shorter time 193 
between onset and intervention, less likely to have known hypertension and less likely to be 194 
taking aspirin (Table II in Supplementary Files). Mean age of the participants was 68.1 years, 195 
39.2% were female, 91.1% had AIS, and 8.9% had ICH. The median pretreatment NIHSS 196 
score was 4 (interquartile range, 2 to 9). Time from stroke onset to commencement of head 197 
positioning was 14 hours (interquartile range, 5 to 38). Other baseline characteristics are 198 
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presented in Table 1.  Mean systolic BP was 156±28mmHg and diastolic BP 87±17mmHg, 199 
with mean systolic BP showed a steady fall over the first 24 hours following randomization 200 
(Fig. 2). Baseline characteristics by randomized treatment demonstrated higher incidence of 201 
coronary artery disease and heart failure in the sitting-up group (Table III in Supplementary 202 
Files). The acute values for systolic BPV demonstrated a mean SBP of 145±18.9mmHg, SD 203 
of 11±7.5mmHg and CV of 8±4.4mmHg (Table IV in Supplementary Files). For diastolic 204 
BPV, SD was 8±4.2mmHg and CV 9±5.3mmHg (Table IV in Supplementary Files). 205 
Overall, increased systolic BPV parameters were all associated with unfavorable shift of the 206 
mRS at 90 days except VIM (Table 2). Systolic BPV assessed using CV demonstrated a 207 
significant linear association with unfavorable shift of the mRS at 90 days (odds ratio [OR] 208 
effect of 1 SD increment of CV, 1.06 [95% confidence interval] 1.02-1.10; P=0.0065 (Table 209 
2). Mean systolic BP (1.21 [1.16-1.25]; P<0.0001) and SD of systolic BP (1.10 [1.05-1.15]; 210 
P<0.0001) both demonstrated significant associations with unfavorable shift in mRS at 90 211 
days. There was no heterogeneity of the association by randomized head positioning. The 212 
trend in mean systolic BP and SD of systolic BP demonstrated a progressive downward trend 213 
from 0-12 hours and a plateau from 12-24 hours (Fig. 2). A positive trend was seen for 214 
association of fifths of CV of SBP and unfavorable shift on the mRS at 90 days (Fig. 3). The 215 
P-value of proportional odds assumption for the model of CV and ordinal outcome was 216 
0.0008. The trend demonstrated a consistent risk relationship between differing levels of the 217 
ordinal outcome measure. This was demonstrated by mRS 0-3 vs. 4-6 (1.07 [1.01-1.13); 218 
P=0.026), mRS 0-4 vs. 5-6 (1.10 [1.03-1.17]; P=0.004) and mRS 0-5 vs. 6 (1.14 [1.06-1.22]; 219 
P=0.001); showing an increasing association of CV of systolic BP with outcome. 220 
With respect to head position, there were no significant changes in systolic BP over 24 hours 221 
by randomized intervention (lying-flat or sitting-up) (Fig. I in the Supplementary Files). Mean 222 
systolic BP was higher in ICH (149±19) patients compared to AIS (144±19) at successive 4-223 
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hourly intervals over the initial 24-hour period (P<0.0001) (Fig. II in the Supplementary 224 
Files). The subgroup analysis by AIS etiology, stroke subtype and head position did not 225 
demonstrate any significant associations with adverse outcome from greater systolic BPV 226 
(Table 3). 227 
Lastly, increased mean diastolic BP (1.08 [1.03-1.12]; P=0.001) and mean arterial pressure 228 
(1.06 [1.01-1.10]; P=0.009) were associated with unfavorable shift of the mRS at 90 days. 229 
(Table V in the Supplementary Files). In addition, CV of diastolic BP (DBP) (1.08, 1.03-1.12; 230 
P=0.001) over 24 hours post stroke, was significantly associated with 3-month poor outcome 231 
(Table V in Supplementary Files). The association was more apparent in sitting-up position 232 
(1.12, 1.06-1.19) compared with lying-flat position (1.03, 0.98-1.09) (P interaction = 0.005). 233 
Among patients without AF, mean SBP (1.17 [1.12-1.22]; P<0.0001), SD (1.05 [1.01-1.09]; 234 
P<0.017), ARV (1.06 [1.01-1.12]; P<0.015), DBP (1.01 [1.00-1.02]; P<0.004) and pulse 235 
pressure (1.02 [1.01-1.03]; P<0.001) were associated with death or disability at 90 days 236 
(Table VI in Supplementary Files).  237 
Discussion 238 
Firstly, these post-hoc analyses of the large multicenter HeadPoST trial demonstrated that 239 
increased BPV is associated with poor outcome from stroke as determined by unfavorable 240 
shift in mRS at 90 days. Secondly, there was no interaction of AIS etiology, stroke sub-type, 241 
head-position or use of reperfusion therapy with the predictive effects of BPV on outcome. 242 
Lastly, head position change did not influence systolic BP over the 24-hour period post 243 
stroke.  244 
The HeadPoST study design provided an opportunity to test the predictive significance of 245 
BPV across the broad range of patients with acute stroke. The paucity of randomized data 246 
examining head position, and central and peripheral hemodynamics are also apparent. 247 
Furthermore, there are no randomized data to date examining head position and BPV 248 
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parameters specifically. BPV is an important measure as it provides information on systemic 249 
hemodynamics and can be used for risk assessment. Challenges exist around beat-to-beat 250 
BPV measurements and translation into clinical practice.  251 
BPV was assessed from multiple readings taken at various time points after hospital 252 
admission for acute stroke [11]. While heterogeneity exists across the methods of assessment 253 
and BPV metrics used in reporting [11], SD correlates well with mean BP levels and the 254 
number of readings and time period do not generally affect the magnitude of short-term BPV, 255 
though mean BP should always be adjusted for as a consequence of this relationship [11]. 256 
Furthermore, this analysis describes the minimum criteria for reporting as determined by a 257 
recent systematic review and meta-analysis (timing, number of BP measurements, duration of 258 
BP monitoring, and a low computational complexity BPV metric) [11]. Importantly, mean 259 
SBP, SD and ARV are crucial confounders as they are often correlated with systolic BPV 260 
[12,13]. ARV was developed as a measure to overcome deficiencies in the commonly used 261 
SD and was largely targeted for use when sampling BP from prolonged ambulatory BP 262 
devices as opposed to casual cuff measurements. Therefore, the focus on measures of BPV 263 
that are not closely correlated with mean SBP, CV and VIM, is key. CV is the most 264 
appropriate index of BPV within this clinical context as it is largely independent of mean SBP 265 
at an individual patient level. This study demonstrated CV to be highly predictive of an 266 
unfavorable outcome as demonstrated by association of worsening fifths of CV with poorer 267 
mRS scores. Interestingly, this study demonstrated DBP variability was also independently 268 
associated with outcome after multivariable adjustment. Though the effect size was small, this 269 
is of interest both pathophysiologically and clinically, particularly as sitting up conferred a 270 
greater magnitude of DBP variability. This appears to be the first time this has been reported, 271 
perhaps largely potentiated by the primary focus of prior work on SBP variability. 272 
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Nevertheless, this finding warrants further observation in mechanistic studies of central and 273 
peripheral blood pressure changes during alteration in head positioning. 274 
Overall, the data from this study do provide support for validation of targeted strategies aimed 275 
at improving BPV independent of head position [14]. Currently there are a lack of data to 276 
support a prognostic benefit, although there have been calls for randomized controlled trials 277 
of interventions to reduce BPV [15]. The basis of such recommendations is in part also due to 278 
the effect of pre-stroke anti-hypertensive therapies on certain BPV parameters, with those on 279 
beta-blocker therapy being reported as having higher SD and VIM but not CV of SBP at 2 280 
weeks [15]. This heterogeneity could explain the borderline VIM result as compared to other 281 
parameters, particularly as 65.5% of the cohort had a diagnosis of hypertension with wide 282 
variation in anti-hypertensive agent use being expected in part due to the geographical 283 
variation of study participants.  284 
A key strength of this study is the consecutive unselected recruitment strategy, which 285 
provided information on a mixture of unstratified stroke pathologies independent of vascular 286 
imaging. This is crucial, as uncertainty remained due to discordance between findings from 287 
post-hoc analyses of INTERACT2 [3] (only ICH patients), compared with the Controlling 288 
Hypertension and Hypotension Immediately Post Stroke (CHHIPS) [16] and the Continue or 289 
Stop Post-Stroke Antihypertensives Collaboration Study (COSSACS) [17] (which were 290 
largely AIS patients). The findings of this study support those from INTERACT2 where 291 
greater systolic BPV was associated with a poor outcome in acute stroke due to ICH, though 292 
do support those from the mixed CHHIPS and COSSACS patient cohorts where no 293 
significant association was found. The differing study design and timing of BPV assessments 294 
may account for the concordance of the findings of this analysis with the INTERACT2 BPV 295 
analysis and consequent discordance with CHHIPS AND COSSACS BPV analysis [15]. 296 
Firstly, this study and INTERACT2 included a comparable number of ICH patients for whom 297 
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arguably BPV demonstrates greater relevance from a prognostic perspective based on 298 
underlying mechanisms precipitating neuropathological deterioration. In addition, in the 299 
INTERACT2 BPV analysis both diastolic BP and mean arterial pressure appeared to confer 300 
some value in predicting prognosis at 30 days, which was confirmed in the present study. 301 
Secondly, the BPV data from INTERACT2 were gathered in the immediate aftermath of 302 
hyperacute stroke (within 6 hours) as opposed to in the acute period in CHHIPS AND 303 
COSSACS (36-48 hours).  304 
Thirdly, as stated in the results section, those excluded were more likely to be female, have a 305 
shorter time between onset and intervention, less likely to have known hypertension and less 306 
likely to be taking aspirin. The reasons for exclusion included a lack of mean systolic BP, 90-307 
day mRS or a final diagnosis that was indeterminate, stroke mimic, or TIA. The impact of 308 
missing data on the analyses is unclear though it could be argued that these individuals are 309 
healthier and hence the results could have provided an overestimation. However, should they 310 
have had a diagnosis of stroke, the shorter time between onset and intervention may have 311 
provided more robust BPV data in the hyperacute post-stroke period. Furthermore, sex 312 
differences do exist in severity of strokes and survival, and therefore the increased likelihood 313 
of exclusion of females may have attributed to a milder stroke population as stroke is often 314 
more severe in a female population [18]. Importantly, further analyses of patients without AF 315 
(Table VI in Supplementary Files), showed significant associations between pulse pressure 316 
and outcome. These findings suggest that the presence of AF confounds any effect pulse 317 
pressure has on outcome. These findings support those of the Standard Medical Management 318 
in Secondary Prevention of Ischemic Stroke in China (SMART) study that demonstrated 319 
pulse pressure was associated with poor stroke outcome in those over 60 years of age without 320 
AF [19].  321 
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A key limitation is the heterogeneity posed by assessment of BPV from standard isolated 322 
measurements as opposed to beat-to-beat assessment. However, BP readings were taken 323 
according to standard practice guidelines in participating hospitals, which are likely to be in 324 
accordance with national guidelines in respect of device, positioning and degree of acceptable 325 
measurement error. In addition, the inclusion of patients with atrial fibrillation presents a risk 326 
of excess unquantifiable variation during BPV assessments as compared to those in sinus 327 
rhythm [20].  328 
The HeadPoST study generally included strokes of mild to moderate severity (median NIHSS 329 
of 4) and most people recruited had a 90-day mRS of 0-1 [9]. However despite patients 330 
presenting late and the intervention being delivered within 24 hours of admission as opposed 331 
to onset, findings of the study were consistent across all categorical scores on the NIHSS at 7 332 
days [9]. The ability to assess the impact of BPV on early neurological deterioration is 333 
therefore limited, though data presented in this analysis provide 90-day prognostic 334 
information despite this. Prior work demonstrating systolic BPV as a cause for poorer 335 
neurological outcome post AIS showed increased systolic BPV was associated with large 336 
lesion core volume, proximal vessel occlusion and good collaterals [21]. Arguably this study 337 
was not representative of this population, who often fail or are not eligible for reperfusion 338 
therapies, though it provides prognostic information about BPV metrics in less severe strokes. 339 
Therefore, there is inadequate power to examine associations in specific etiological subtypes 340 
of ischemic stroke. Nonetheless, all other data, derived from observational and clinical trial 341 
settings, suggest consistency in risk factors and prognostic variables across such subtypes.  342 
This secondary analysis did not assess the BP lowering efficacy of certain anti-hypertensive 343 
agents and the consequent efficacy in preventing adverse cardiovascular outcomes as a 344 
consequence of uncontrolled BPV. Finally, the limited number of patients with large artery 345 
occlusions, with or without mechanical thrombectomy intervention, limits generalizability to 346 
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those individuals often at the peaks of systolic BP values, though the inclusion of those with 347 
ICH provides some perspectives on stroke severity and extremes of BP. Further work 348 
examining BPV metrics in a more severe subset of AIS patients is warranted including those 349 
undergoing mechanical reperfusion interventions. 350 
In conclusion, increased BPV is associated with poor outcome from stroke as determined by 351 
unfavorable shift in mRS at 90 days. Head position has no influence on BPV in the largest 352 
randomized study of nursing care following acute stroke to date. 353 
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Table Legend 
Table 1: Baseline characteristics of the 9,156 patients with acute stroke and 4-hourly 
blood pressure parameters for 24 hours included in the analysis 
Table 2: Association of SBP variability with unfavorable shift of the mRS at 90 days 
Table 3: Multivariate subgroup analysis by AIS etiology, stroke sub-type, head 
position and reperfusion therapy 
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Table 1: Baseline Characteristics 
 Overall (N=9156) 
Socio-demographic characteristics  
Female sex 3587 (39.2) 
Age (years) 68.1 (13.5) 
Region of Recruitment  
   Australia and UK 3383 (36.9) 
   South America 802 (8.8) 
   China (incl. Taiwan) 4281 (46.8) 
   India and Sri Lanka 690 (7.5) 
Time from stroke onset to commencing intervention 
(hrs) 
15.0 (5.0 – 38.0) 
Time from admission to commencing intervention 
(hrs) 
8.0 (2.0 – 29.0) 
Stroke type§  
   AIS 8324 (91.1) 
   ICH 817 (8.9) 
Pre-stroke mRS of 0 5595 (61.1) 
NIHSS at admission 4.0 (2.0 – 9.0) 
GCS score on arrival 15.0 (14.0 – 15.0) 
Vital signs and laboratory results  
Systolic BP (mmHg) 155.5 (27.5) 
Diastolic BP (mmHg) 86.7 (16.6) 
Heart Rate (bpm) 76.0 (68.0 – 84.0) 
Glucose (mmol/l) 5.5 (4.9 - 6.1) 
Serum Creatinine (mmol/l) 75.0 (63.0 – 90.0) 
Medical History  
Previous stroke 2164 (23.7) 
Coronary artery disease 1238 (13.6) 
Atrial fibrillation 960 (10.6) 
Heart Failure 325 (3.6) 
Hypertension 5981 (65.5) 
Diabetes Mellitus 2235 (24.5) 
Current Smoker 1799 (19.8) 
Medications at time of admission  
Aspirin 4092 (44.7) 
Other antiplatelet agent 1836 (20.1) 
Anticoagulant 779 (8.5) 
Swallow screen on admission 7155 (78.2) 
Swallow assessment on admission 3341 (36.5) 
Data are n (%), mean (standard deviation) or median (interquartile range). 
AIS: acute ischemic stroke; ICH: intracerebral hemorrhage; mRS: modified 
Rankin score; NIHSS: National Institutes of Health stroke scale; GCS: 
Glasgow coma scale; BP: blood pressure. 
     §Reported by clinician investigator from brain imaging and other 
investigations on hospital discharge.
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Table 2 Association of SBP variability with unfavorable shift of the mRS at 90 days 
 Univariate analysis Multivariate Model  
 OR(95%CI) P value OR(95%CI) P value 
Mean 1.26(1.21-1.31) <0.0001 1.21(1.16-1.25) <0.0001
MIN 1.18(1.14-1.23) <0.0001 1.15(1.11-1.20) <0.0001
MAX 1.28(1.23-1.33) <0.0001 1.21(1.16-1.26) <0.0001
SD 1.17(1.12-1.23) <0.0001 1.10(1.05-1.15) <0.0001
CV 1.11(1.06-1.15) <0.0001 1.06(1.02-1.10) 0.0065
ARV 1.17(1.11-1.22) <0.0001 1.12(1.06-1.17) <0.0001
RSD 1.13(1.08-1.18) <0.0001 1.08(1.04-1.13) 0.0002
VIM 1.08(1.04-1.13) <0.0001 1.04(1.00-1.08) 0.0533
CV: coefficient of variation; ARV: average absolute difference between successive BP measurements; RSD: residual SD; VIM: 
variation independent of mean. 
 
Data are presented as odds ratio [OR] (95% confidence intervals [95%CI]) for per 1 unit increment of systolic blood pressure [SBP] 
variability (i.e. for SD, the unit is 1 SD of SD; for CV, the unit is 1 SD of CV; for ARV, the unit is 1 SD of ARV; for RSD, the unit is 1 
SD of RSD; and for VIM, the unit is 1 SD of VIM). 
 
Multivariable Model: Adjusted for country, prestroke mRS score, sex, baseline NIHSS score, and history of heart disease, stroke, 
diabetes mellitus, or hypertension, prior antiplatelet therapy 
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Table 3 Multivariate subgroup analysis by AIS etiology, stroke sub-type and head position 
  Multivariable analysis  
AIS  OR(95%CI) P interaction 
Large artery occlusion due to 
significant extracranial internal 
carotid atheroma 
N=654 1.05(0.90-1.23) 0.333
Large artery occlusion due to 
significant intracranial cerebral 
atheroma 
N=2004 1.03(0.94-1.13)
Small vessel or perforator lacunar 
disease 
N=2580 1.06(0.98-1.16)
Others N=3094 1.08(1.01-1.16)
Stroke subtype  
AIS N=8338 1.06(1.01-1.11) 0.908
ICH N=818 1.03(0.94-1.13)
Head position
Lying flat N=4375 1.04(0.98-1.10) 0.120
Sitting up N=4781 1.08(1.02-1.15)
Reperfusion therapy  
No N=7183 1.05(1.00-1.10) 0.139
Yes N=1115 1.04(0.93-1.17)
 
Data are presented as odds ratio [OR] (95% confidence intervals [95%CI]) for per 1 unit increment of systolic blood pressure [SBP] 
variability. AIS: acute ischemic stroke; ICH: intracerebral hemorrhage. 
 
Adjusted covariates include covariates of country, prestroke mRS score, sex, baseline NIHSS score, and history of heart disease, 
stroke, diabetes mellitus, or hypertension, and prior antiplatelet therapy  
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Figure Legend 
Fig. 1: Flowchart of the study procedures  
Fig. 2: Mean and SD of systolic blood pressure over time 
Fig. 3: Association between fifths of coefficient of variation of systolic blood 
pressure and unfavorable shift of mRS at 90 days 
Footnote: Association between fifths of CV of systolic blood pressure at baseline and 
unfavorable shift of mRS at 90 days 
 
HeadPoST patients 
N=11093 
9156 patients were included 
in the analyses 
Excluding patients:  
         without a mean systolic blood pressure (n=46) 
         without 90-day modified Rankin Scale (n=1214) 
         with a stroke mimic, transient ischemic attack 
          or undetermined diagnosis (n=677)  
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